{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-08",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Richmond",
      "state": "VA",
      "country": "United States",
      "classification": "Class II",
      "openfda": {
        "application_number": [
          "NDA020213"
        ],
        "brand_name": [
          "MIOCHOL E"
        ],
        "generic_name": [
          "ACETYLCHOLINE CHLORIDE"
        ],
        "manufacturer_name": [
          "Bausch & Lomb Incorporated"
        ],
        "product_ndc": [
          "24208-539"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "rxcui": [
          "876551",
          "876553"
        ],
        "spl_id": [
          "19c42ee4-9f98-48da-85ea-52090070c2e2"
        ],
        "spl_set_id": [
          "e701ef07-9499-4b56-931f-f4eb3eedbe24"
        ],
        "package_ndc": [
          "24208-539-20"
        ],
        "is_original_packager": [
          true
        ]
      },
      "product_type": "Drugs",
      "event_id": "89646",
      "recalling_firm": "Mckesson Medical-Surgical Inc. Corporate Office",
      "address_1": "9954 Maryland Drive",
      "address_2": "Deep Run Iii Ste. 4000",
      "postal_code": "23233",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "USA nationwide.",
      "recall_number": "D-0994-2022",
      "product_description": "Miocol-E (acetylcholine chloride intraocular solution) 20 mg/2mL (10 mg/mL), Rx only, Manufacturer: Bausch & Lomb, NDC 24208-539-20",
      "product_quantity": "45 kits",
      "reason_for_recall": "cGMP deviations: Temperature abuse",
      "recall_initiation_date": "20220413",
      "center_classification_date": "20220609",
      "termination_date": "20231130",
      "report_date": "20220615",
      "code_info": "McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer.     The letters clearly explain that consignees should identify product received from MMS between June 1 and September 30, 2021. A consignee should be able to use its own records to determine whether it received an impacted product from MMS during that timeframe and whether it still has any of that product in inventory. The recall notification letter informs consignees that they may contact Sedgwick if they have any questions.",
      "more_code_info": ""
    }
  ]
}